Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$25.86 - $46.71 $3.09 Million - $5.59 Million
119,617 Added 440.71%
146,759 $6.82 Million
Q1 2023

May 10, 2023

BUY
$26.05 - $32.31 $707,049 - $876,958
27,142 New
27,142 $777,000
Q4 2021

Feb 14, 2022

SELL
$22.41 - $37.54 $914,328 - $1.53 Million
-40,800 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$31.92 - $37.0 $1.3 Million - $1.51 Million
40,800 New
40,800 $1.34 Million

Others Institutions Holding DICE

About DICE Therapeutics, Inc.


  • Ticker DICE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,430,000
  • Description
  • DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...
More about DICE
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.